Gadek Thomas R相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease

利非格司特的研发：一种用于治疗干眼症的新型T细胞抑制剂

doi:10.2147/OPTH.S110557

Semba, Charles P; Gadek, Thomas R

细胞生物学

免疫/内分泌

发表日期：2016

文献求助收藏

Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118)

LFA-1拮抗剂利非格司特（SAR 1118）可抑制角膜炎症。

期刊:Journal of Ocular Pharmacology and Therapeutics

影响因子:2.1

doi:10.1089/jop.2012.0102

Sun, Yan; Zhang, Rui; Gadek, Thomas R; O'Neill, Charles A; Pearlman, Eric

发表日期：2013

文献求助收藏

Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye

发现并开发强效LFA-1/ICAM-1拮抗剂SAR 1118作为治疗干眼症的眼用溶液

期刊:ACS Medicinal Chemistry Letters

doi:10.1021/ml2002482

Zhong, Min; Gadek, Thomas R; Bui, Minna; Shen, Wang; Burnier, John; Barr, Kenneth J; Hanan, Emily J; Oslob, Johan D; Yu, Chul H; Zhu, Jiang; Arkin, Michelle R; Evanchik, Marc J; Flanagan, W Mike; Hoch, Ute; Hyde, Jennifer; Prabhu, Saileta; Silverman, Jeffrey A; Wright, Jasmin

发表日期：2012

文献求助收藏

Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1.

细胞间粘附分子-1 与小分子拮抗剂竞争淋巴细胞功能相关抗原-1 α1 亚基上的共同结合位点

期刊:Protein Science

影响因子:5.2

doi:10.1110/ps.051583406

Keating Susan M, Clark Kevin R, Stefanich Lisa D, Arellano Fred, Edwards Caroline P, Bodary Sarah C, Spencer Steven A, Gadek Thomas R, Marsters James C Jr, Beresini Maureen H

细胞生物学

发表日期：2006

文献求助收藏